Faecal microbiota transplantation for Clostridium difficile‐associated diarrhoea: a systematic review of randomised controlled trials

@article{Moayyedi2017FaecalMT,
  title={Faecal microbiota transplantation for Clostridium difficile‐associated diarrhoea: a systematic review of randomised controlled trials},
  author={P. Moayyedi and Y. Yuan and Harith Baharith and A. Ford},
  journal={Medical Journal of Australia},
  year={2017},
  volume={207}
}
  • P. Moayyedi, Y. Yuan, +1 author A. Ford
  • Published 2017
  • Medicine
  • Medical Journal of Australia
  • Objectives: Faecal microbiota transplantation (FMT) has emerged as a useful approach for treating Clostridium difficile‐associated diarrhoea (CDAD). Randomised controlled trials (RCTs) have recently evaluated its effectiveness, but systematic reviews have focused on evidence from case series. We therefore conducted a systematic review and meta‐analysis of RCTs evaluating the effectiveness of FMT for treating CDAD. 
    61 Citations

    Paper Mentions

    Fecal microbiota transplantation for recurrent Clostridium difficile infection
    • 9
    • PDF
    Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections
    • 30
    • Highly Influenced
    • PDF
    Is a Single Fecal Microbiota Transplant a Promising Treatment for Recurrent Clostridium difficile Infection?
    • 5
    Management of Primary and Recurrent Clostridium difficile Infection: An Update
    • 7
    • PDF

    References

    SHOWING 1-10 OF 41 REFERENCES
    Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review
    • 41
    Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review.
    • 159
    • PDF
    Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
    • 166
    Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study.
    • I. Youngster, J. Sauk, +7 authors E. Hohmann
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2014
    • 346
    • PDF
    Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial
    • S. Hota, V. Sales, +6 authors S. Poutanen
    • Medicine
    • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
    • 2017
    • 89
    • PDF